Byung-Jae Yoo (49) was appointed the head of the integrated Novartis Korea. Suhee Shin, General Manager of the Oncology Business Unit at Novartis submitted her resignation.

According to industry sources, Novartis Korea has been integrating its Pharmaceuticals and Oncology Business Unit with the goal of completing the integration within the year.

The company had been operating 2 business units independently under one name, but the two units have operated separate support departments, including marketing·sales as well as drug pricing·government relations·approval departments.

In the integration process, the business units will be competing for the head position of each